• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
    • Why Should You Support SAGES?
    • SAGES Swag
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Annual Meeting
      • 2027 Scientific Session Call for Abstracts
      • 2027 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • SAGES Lead Up Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • Innovative Surgical Trends
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Advanced Laparoscopy and Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
    • Foregut Video Atlas
  • Opportunities
    • Join the SAGES Patient Partner Network (PPN)
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs
  • Learning Hub
You are here: Home / Abstracts / Predicting Remission of Type-2 Diabetes With Ileal Interposition With Sleeve Gastrectomy

Predicting Remission of Type-2 Diabetes With Ileal Interposition With Sleeve Gastrectomy

Surendra Ugale, MS, Neeraj Gupta, MBBS, Vishwas Naik, MS, Kd Modi, MD, Sunil Kota. Kirloskar Hospital and Medwin Hospitals, Hyderabad, Andhra Pradesh, India

 

Aim- Combination of Laparoscopic Ileal Interposition with sleeve gastrectomy offers good metabolic improvement and weight reduction without causing significant malabsorption.
In a country with more than 62 million diabetics, India can soften the impact of rising healthcare costs in an environment of good economic growth, if resources are focused on selected group of patients, with impending complications of nephropathy, retinopathy or cardiac disease, by using factors predicting successful outcomes after Ileal Interposition
Methods- The II&SG was performed in 43 patients (M:F=26:17) from January 2008. Participants had mean age of 47.53± 8.82 years (range 29-64 years), mean duration of diabetes 9.75± 8.82 years (range- 1 to 32 years) and mean preoperative BMI 32.05 ± 7.5 kg/mt2. All patients had poorly controlled type 2 diabetes mellitus (mean HbA1C- 9.57 ± 2 %) despite use of oral hypoglycemic agents (OHA) and/or Insulin. Thirty (70%) patients had hypertension, 19 (44%) had dyslipidemia and 19 (44%) had significant microalbuminuria.
Results- Mean follow up was 11.3 ± 9 months (range: 1-32 months). Postoperatively glycemic parameters (FBS, PLBS, HbA1C) improved in all patients (p<0.05) at all intervals. Eighteen patients (45%) had remission in diabetes and the remaining patients showed significant reduction in AHA dosage. significantly decreased OHA requirement. All patients had weight loss between 15%-30% (p<0.05). Twenty seven patients (90%) had remission in hypertension. At 2 years mean fall in HbA1C (36%) was more than reduction in BMI(20%). There was a declining trend in lipids and microalbuminuria postoperatively.
Remission of diabetes and Hypertension and metabolic improvement was clearly more in patients with BMI > 27 kg/mt2 , duration of diabetes ≤ 10 years and stimulated C-peptide > 4 ng/ml.
Conclusions- Laparoscopic Ileal Interposition with sleeve gastrectomy, based on the principle of neuroendocrine brake, appears to be safe and a potentially effective option for remission of type 2 diabetes. Hypertension is a major risk factor for cardiovascular disease and micro vascular complications such as retinopathy and nephropathy. Seventy five percent of our patients (30/43) had hypertension. In majority of them i.e. 27/30 (90%) hypertension subsided after surgery Patients with shorter duration of diabetes, higher BMI and higher stimulated C-peptide values would respond better, enabling a focused utilization of scarce resources, to prevent major complications like nephropathy, retinopathy & cardiac events, to avoid the large financial drain on the country’s economy
 

POSTOPERATIVE GLYCEMIC IMPROVEMENT (HbA1C) IN PATIENTS CLASSIFIED AS PER THEIR PREOPERATIVE BMI, DURATION OF DIABETES AND STIMULATED C-PEPTIDE LEVELS.

 

             
             
             
             
             
             
             
             
             

 


Session Number: Poster – Poster Presentations
Program Number: P505
View Poster

Related



Hours & Info

15821 Ventura Blvd Ste 400
Encino, CA 91436

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2026 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals

Refine Search